Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
Biotech employees’ desire for freedom and flexibility is ‘here to stay,’ survey finds
Medical Marketing and Media
Thu, 10/20/22 - 11:31 pm
biotech
COVID-19
pandemic
hybrid work
remote work
Pfizer CEO Bourla says company ready to execute in a 'pivotal' 2023: report
Fierce Pharma
Thu, 10/20/22 - 10:48 am
Pfizer
Pharma CEOs
Albert Bourla
drug launches
COVID-19
vaccines
Everest and Providence report positive Phase II data for Covid-19 vaccine
Clinical Trials Arena
Thu, 10/20/22 - 10:43 am
Everest Medicines
Providence Therapeutics
vaccines
MRNA
COVID-19
PTX-COVID19-B
Apogenix’s asunercept shown to offer benefits in Phase II Covid-19 trial
Clinical Trials Arena
Thu, 10/20/22 - 10:33 am
Apogenix
clinical trials
asunercept
COVID-19
FDA authorizes Novavax’s Covid-19 booster, a first for a protein-based vaccine
MedCity News
Wed, 10/19/22 - 10:56 pm
Novavax
vaccines
COVID-19
boosters
FDA
Gilead touts Veklury resilience against mutated coronavirus, plots phase 3 for new COVID oral antiviral
Fierce Pharma
Wed, 10/19/22 - 11:03 am
Gilead Sciences
COVID-19
clinical trials
Veklury
After matching Comirnaty, Providence plans phase 3 booster study for COVID-19 vaccine candidate
Fierce Biotech
Wed, 10/19/22 - 10:57 am
Providence Therapeutics
COVID-19
vaccines
boosters
MRNA
Abbott sales dip in Q3 due to COVID testing sales declines, infant formula manufacturing stoppage
Medical Marketing and Media
Wed, 10/19/22 - 10:47 am
Abbott Labs
earnings
Medtech
infant formula
COVID-19
FDA device center guidance priority lists targets COVID, digital health
RAPS.org
Tue, 10/18/22 - 10:03 pm
FDA
COVID-19
digital health
COVID vaccine boosts J&J pharma sales in Q3
Medical Marketing and Media
Tue, 10/18/22 - 10:53 am
JNJ
COVID-19
vaccines
earnings
Roche Q3 results show steep fall-off in COVID product sales
Pharmaphorum
Tue, 10/18/22 - 10:50 am
Roche
earnings
COVID-19
Moderna halts vaccine supply to COVAX in favor of new agreement for omicron-adjusted shots in 2023
Fierce Pharma
Mon, 10/17/22 - 11:36 pm
Moderna Therapeutics
COVAX
vaccines
boosters
COVID-19
Omicron variant
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
biopharma stocks
COVID-19
Eli Lilly
Bristol Myers Squibb
Merck
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Neurocrine
Sarepta Therapeutics
Orion
Pfizer
GSK
Roche
Moderna Therapeutics
BeiGene
BioNTech
Novavax
CureVac
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
Yahoo/Businesswire
Thu, 10/13/22 - 09:26 am
Pfizer
BioNTech
clinical trials
COVID-19
vaccines
boosters
bivalent boosters
FDA authorizes Moderna and Pfizer-BioNTech Bivalent COVID vaccines for booster doses in younger age groups
Pharma Live
Wed, 10/12/22 - 10:36 am
FDA
Pfizer
Moderna Therapeutics
BioNTech
vaccines
boosters
bivalent boosters
COVID-19
pediatric
FWIW, Pfizer exec denies company negotiated vaccine deal with Europe via text messages
Fierce Pharma
Tue, 10/11/22 - 04:14 pm
Pfizer
Pharma CEOs
Albert Bourla
vaccines
COVID-19
Europe
AstraZeneca’s Covid-19 nasal-spray version fails in trial
Clinical Trials Arena
Tue, 10/11/22 - 10:45 am
AstraZeneca
COVID-19
vaccines
clinical trials
intranasal vaccines
When Will Novavax Vaccines Be FDA Authorized As Covid-19 Boosters?
Forbes
Mon, 10/10/22 - 10:51 am
Novavax
vaccines
boosters
COVID-19
FDA
Ascletis doses healthy subjects in Phase I trial of oral Covid-19 tablets
Clinical Trials Arena
Mon, 10/10/22 - 10:43 am
Ascletis Pharmaceuticals
clinical trials
COVID-19
ASC10
Merck Covid antiviral pill did not cut hospitalization risk, study finds
Financial Times
Sun, 10/9/22 - 06:08 pm
Merck
COVID-19
molnupiravir
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
…
next ›
last »